Cravath’s London Office Moves to 100 Cheapside

LMG Life Sciences Honors Cravath with 2025 Impact Deal Award

September 11, 2025

On September 5, 2025, LMG Life Sciences honored Cravath at the publication’s 2025 Americas Awards, which recognize “top firms, attorneys and in‑house counsel for their work in the life sciences industry over the past year.” The Firm was honored with an Impact Deal of the Year award for its representation of Johnson & Johnson in its $14.6 billion acquisition of Intra Cellular Therapies, Inc.

Related Practices & Industries

Deals & Cases

January 13, 2025

Johnson & Johnson’s $14.6 Billion Acquisition of Intra‑Cellular Therapies, Inc.

On January 13, 2025, Johnson & Johnson and Intra‑Cellular Therapies, Inc. announced that they have entered into a definitive agreement under which Johnson & Johnson will acquire all outstanding shares of Intra‑Cellular Therapies, a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, for $132 per share in cash for a total equity value of approximately $14.6 billion. Cravath is representing Johnson & Johnson in connection with the transaction.

Cravath Bicentennial

Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.

Explore

LMG Life Sciences Honors Cravath with 2025 Impact Deal Award

Related Practices & Industries

Related News & Insights

Johnson & Johnson’s $14.6 Billion Acquisition of Intra‑Cellular Therapies, Inc.

Cravath Bicentennial